Cilastatin sodium for acute kidney injury

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Mar 2025: Trial registered, NCT06886464
  2. 16 Jul 2025: Trial started, NCT06886464

The trials

NCT06886464: Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin

State
Under way
Phase
Phase 2
People
698 planned
Started
16 Jul 2025
Primary completion
31 Dec 2027
Arms
Cilastatin Intervention
Results
None posted
  1. 20 Mar 2025: Trial registered
  2. 16 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Recarbrio component cilastatin sodium.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.